GAPR1_HUMAN - dbPTM
GAPR1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GAPR1_HUMAN
UniProt AC Q9H4G4
Protein Name Golgi-associated plant pathogenesis-related protein 1
Gene Name GLIPR2
Organism Homo sapiens (Human).
Sequence Length 154
Subcellular Localization Golgi apparatus membrane
Lipid-anchor . Binds lipid-enriched microdomains of Golgi membranes not only by ionic interactions but also through the myristate.
Protein Description
Protein Sequence MGKSASKQFHNEVLKAHNEYRQKHGVPPLKLCKNLNREAQQYSEALASTRILKHSPESSRGQCGENLAWASYDQTGKEVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKASASDGSSFVVARYFPAGNVVNEGFFEENVLPPKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Myristoylation------MGKSASKQF
------CCCCHHHHH
32.4011865038
2N-myristoyl glycine------MGKSASKQF
------CCCCHHHHH
32.40-
7Ubiquitination-MGKSASKQFHNEVL
-CCCCHHHHHHHHHH
57.61-
15UbiquitinationQFHNEVLKAHNEYRQ
HHHHHHHHHHHHHHH
53.422189047
23UbiquitinationAHNEYRQKHGVPPLK
HHHHHHHHHCCCHHH
33.07-
30UbiquitinationKHGVPPLKLCKNLNR
HHCCCHHHHHHHCCH
58.58-
33UbiquitinationVPPLKLCKNLNREAQ
CCHHHHHHHCCHHHH
74.94-
42PhosphorylationLNREAQQYSEALAST
CCHHHHHHHHHHHHH
9.0819060867
43PhosphorylationNREAQQYSEALASTR
CHHHHHHHHHHHHHH
16.44-
48PhosphorylationQYSEALASTRILKHS
HHHHHHHHHHHHHCC
21.04-
49PhosphorylationYSEALASTRILKHSP
HHHHHHHHHHHHCCC
19.00-
53UbiquitinationLASTRILKHSPESSR
HHHHHHHHCCCCCCC
39.40-
53AcetylationLASTRILKHSPESSR
HHHHHHHHCCCCCCC
39.4025953088
55PhosphorylationSTRILKHSPESSRGQ
HHHHHHCCCCCCCCC
28.8630266825
58PhosphorylationILKHSPESSRGQCGE
HHHCCCCCCCCCCCC
28.8130266825
59PhosphorylationLKHSPESSRGQCGEN
HHCCCCCCCCCCCCC
38.4830266825
71PhosphorylationGENLAWASYDQTGKE
CCCCEEEEECCCCHH
20.6727251275
77UbiquitinationASYDQTGKEVADRWY
EEECCCCHHHHHHHH
53.02-
88UbiquitinationDRWYSEIKNYNFQQP
HHHHHHHHHCCCCCC
49.69-
98PhosphorylationNFQQPGFTSGTGHFT
CCCCCCCCCCCCEEE
31.9627251275
99PhosphorylationFQQPGFTSGTGHFTA
CCCCCCCCCCCEEEE
31.9027251275
101PhosphorylationQPGFTSGTGHFTAMV
CCCCCCCCCEEEEEE
27.5327251275
119UbiquitinationTKKMGVGKASASDGS
CCCCCCCEEECCCCC
36.44-
123PhosphorylationGVGKASASDGSSFVV
CCCEEECCCCCCEEE
39.7527251275
153UbiquitinationEENVLPPKK------
CCCCCCCCC------
70.00-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of GAPR1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of GAPR1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GAPR1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CAV1_HUMANCAV1physical
11865038
KR103_HUMANKRTAP10-3physical
25416956

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GAPR1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Myristoylation
ReferencePubMed
"Identification and characterization of a novel human plantpathogenesis-related protein that localizes to lipid-enrichedmicrodomains in the Golgi complex.";
Eberle H.B., Serrano R.L., Fuellekrug J., Schlosser A., Lehmann W.D.,Lottspeich F., Kaloyanova D., Wieland F.T., Helms J.B.;
J. Cell Sci. 115:827-838(2002).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 35-49 AND 54-68,SUBCELLULAR LOCATION, MYRISTOYLATION AT GLY-2, AND INTERACTION WITHCAV1.

TOP